These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26637636)

  • 1. Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension.
    Bryant AJ; Carrick RP; McConaha ME; Jones BR; Shay SD; Moore CS; Blackwell TR; Gladson S; Penner NL; Burman A; Tanjore H; Hemnes AR; Karwandyar AK; Polosukhin VV; Talati MA; Dong HJ; Gleaves LA; Carrier EJ; Gaskill C; Scott EW; Majka SM; Fessel JP; Haase VH; West JD; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L249-62. PubMed ID: 26637636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
    Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
    Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
    Hu CJ; Poth JM; Zhang H; Flockton A; Laux A; Kumar S; McKeon B; Mouradian G; Li M; Riddle S; Pugliese SC; Brown RD; Wallace EM; Graham BB; Frid MG; Stenmark KR
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-κB p65/HIF-1α pathway.
    Maimaitiaili N; Zeng Y; Ju P; Zhakeer G; E G; Yao H; Shi Y; Zhai M; Zhuang J; Peng W; Zhuoga D; Yu Q
    Exp Cell Res; 2023 Oct; 431(2):113755. PubMed ID: 37586455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain-1 mediates vascular remodelling and fibrosis via HIF-1α in hypoxia-induced pulmonary hypertension.
    Deng H; Tian X; Sun H; Liu H; Lu M; Wang H
    J Cell Mol Med; 2022 May; 26(10):2819-2830. PubMed ID: 35365973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.
    Liu J; Wang W; Wang L; Chen S; Tian B; Huang K; Corrigan CJ; Ying S; Wang W; Wang C
    EBioMedicine; 2018 Jul; 33():196-210. PubMed ID: 29921553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA Rps4l Mediates the Proliferation of Hypoxic Pulmonary Artery Smooth Muscle Cells.
    Liu Y; Zhang H; Li Y; Yan L; Du W; Wang S; Zheng X; Zhang M; Zhang J; Qi J; Sun H; Zhang L; Li G; Zhu D
    Hypertension; 2020 Oct; 76(4):1124-1133. PubMed ID: 32772647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.
    Ball MK; Waypa GB; Mungai PT; Nielsen JM; Czech L; Dudley VJ; Beussink L; Dettman RW; Berkelhamer SK; Steinhorn RH; Shah SJ; Schumacker PT
    Am J Respir Crit Care Med; 2014 Feb; 189(3):314-24. PubMed ID: 24251580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension.
    Li X; He Y; Xu Y; Huang X; Liu J; Xie M; Liu X
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(4):L299-310. PubMed ID: 26702149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.
    Dai Z; Zhu MM; Peng Y; Machireddy N; Evans CE; Machado R; Zhang X; Zhao YY
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1423-1434. PubMed ID: 29924941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Veith C; Vartürk-Özcan I; Wujak M; Hadzic S; Wu CY; Knoepp F; Kraut S; Petrovic A; Gredic M; Pak O; Brosien M; Heimbrodt M; Wilhelm J; Weisel FC; Malkmus K; Schäfer K; Gall H; Tello K; Kosanovic D; Sydykov A; Sarybaev A; Günther A; Brandes RP; Seeger W; Grimminger F; Ghofrani HA; Schermuly RT; Kwapiszewska G; Sommer N; Weissmann N
    Circulation; 2022 Mar; 145(12):916-933. PubMed ID: 35175782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
    Lin Q; Fan C; Gomez-Arroyo J; Van Raemdonck K; Meuchel LW; Skinner JT; Everett AD; Fang X; Macdonald AA; Yamaji-Kegan K; Johns RA
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2505-2519. PubMed ID: 31597444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.
    Solinc J; Raimbault-Machado J; Dierick F; El Bernoussi L; Tu L; Thuillet R; Mougenot N; Hoareau-Coudert B; Monceau V; Pavoine C; Atassi F; Sassoon D; Marazzi G; Harvey RP; Schofield P; Christ D; Humbert M; Guignabert C; Soubrier F; Nadaud S
    J Am Heart Assoc; 2022 Apr; 11(7):e023021. PubMed ID: 35348002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
    Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
    Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethyl arginine induces pulmonary vascular dysfunction via activation of signal transducer and activator of transcription 3 and stabilization of hypoxia-inducible factor 1-alpha.
    Pekarova M; Koudelka A; Kolarova H; Ambrozova G; Klinke A; Cerna A; Kadlec J; Trundova M; Sindlerova Svihalkova L; Kuchta R; Kuchtova Z; Lojek A; Kubala L
    Vascul Pharmacol; 2015 Oct; 73():138-48. PubMed ID: 26091577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.